Walmart Revolutionizes Insulin Access & Affordability for Patients With Diabetes With the Launch of the First & Only Private ...
June 29 2021 - 8:20AM
Business Wire
Walmart’s exclusive ReliOn™ NovoLog® vials and
FlexPens® will save customers 58% to 75% off the cash price of
branded insulin products.
Walmart announced the launch of the first-ever private brand
analog insulin, which will revolutionize the access and
affordability to diabetes care by offering customers a significant
price savings without compromising quality. Available exclusively
through Walmart’s private ReliOn brand, the new offering includes
analog insulin vials ($72.88) and FlexPen® ($85.88). These products
will save customers1 between 58% to 75% off the cash price of
branded analog insulin products, which translates to a savings of
up to $101 per branded vial or $251 per package of branded
FlexPens®.
The new private label ReliOn™ NovoLog® Insulin (insulin aspart)
injection, manufactured by Novo Nordisk, is available in Walmart
pharmacies this week, and Sam’s Club pharmacies in mid-July across
the United States. ReliOn™ NovoLog® is a rapid-acting insulin
analog used to control high blood sugar in adults and children with
diabetes. Customers will need a prescription in order to purchase
the products and should always consult with their doctor regarding
their diabetes management.
“We know many people with diabetes struggle to manage the
financial burden of this condition, and we are focused on helping
by providing affordable solutions. We also know this is a condition
that disproportionately impacts underserved populations. With
ReliOn NovoLog® insulin, we’re adding a high-quality medication for
diabetes to the already affordable ReliOn line of products and
continuing our commitment to improve access and lowering cost of
care,” said Dr. Cheryl Pegus, executive vice president, Walmart
Health & Wellness.
Walmart is a destination for affordable diabetes resources,
including blood glucose monitors, lancets and other diabetes
management essentials in the ReliOn portfolio. Notably, the
retailer’s suite of affordable diabetes products offers customers
choices when it comes to their diabetes management; however, every
patient is unique and may respond differently to treatment, so the
ultimate treatment decision should be based on their health care
provider's recommendation.
“Diabetes often comes with high medical costs, estimated around
$9,601 per person per year. We welcome all affordable solutions
that make diabetes management more accessible to millions of
Americans living with diabetes. We encourage everyone to ask their
health care provider questions to better understand what the right
and affordable treatment is for their unique medical needs,” said
Tracey D. Brown, chief executive officer of the American Diabetes
Association.
The ReliOn NovoLog® analog insulin offering adds to Walmart’s
history of introducing innovative solutions that increase access to
quality, affordable health care resources, including the
industry-leading $4 generic prescription program launched more than
a decade ago. For additional information about Walmart’s affordable
diabetes resources, visit Walmart.com/diabetes.
1 The out-of-pocket costs patient pay for
insulin depends on a variety of factors. These savings have been
calculated based on patients purchasing these insulins without
prescription drug insurance.
About Walmart
Walmart Inc. (NYSE: WMT) helps people around the world save
money and live better - anytime and anywhere - in retail stores,
online, and through their mobile devices. Each week, approximately
220 million customers and members visit approximately 10,500 stores
and clubs under 48 banners in 24 countries and eCommerce websites.
With fiscal year 2021 revenue of $559 billion, Walmart employs over
2.3 million associates worldwide. Walmart continues to be a leader
in sustainability, corporate philanthropy and employment
opportunity. Additional information about Walmart can be found by
visiting corporate.walmart.com, on Facebook at facebook.com/walmart
and on Twitter at twitter.com/walmart.
Indications and Usage
What is NovoLog® (insulin aspart) injection?
- NovoLog® is a man-made insulin used to control high blood sugar
in adults and children with diabetes mellitus.
Important Safety Information
Do not share your NovoLog® FlexPen®, NovoLog® FlexTouch®,
PenFill® cartridge or PenFill® cartridge compatible insulin
delivery device with other people, even if the needle has been
changed. You may give other people a serious infection, or get a
serious infection from them.
Who should not take NovoLog®?
Do not take NovoLog® if:
- your blood sugar is too low (hypoglycemia) or you are allergic
to NovoLog® or any of its ingredients.
Before taking NovoLog®, tell your health care provider about
all your medical conditions including, if you are:
- pregnant, plan to become pregnant, or are breastfeeding.
- taking new prescription or over-the-counter medicines,
including supplements.
Talk to your health care provider about how to manage low
blood sugar.
How should I take NovoLog®?
- Read the Instructions for Use and take exactly as
directed.
- NovoLog® starts acting fast. Eat a meal within 5 to 10
minutes after taking it.
- Know the type and strength of your insulin. Do not
change your insulin type unless your health care provider tells you
to.
- Check your blood sugar levels. Ask your health care
provider what your blood sugar levels should be and when you should
check them.
- Do not reuse or share your needles with other people.
You may give other people a serious infection, or get a serious
infection from them.
- Change (rotate) your injection sites within the area you
choose with each injection to reduce your risk of getting
lipodystrophy (pits in skin or thickened skin) and localized
cutaneous amyloidosis (skin with lumps) at the injection sites.
- Do not use the exact same spot for each injection.
- Do not inject where the skin has pits, is thickened, or
has lumps.
- Do not inject where the skin is tender, bruised, scaly
or hard, or into scars or damaged skin.
What should I avoid while taking NovoLog®?
- Do not drive or operate heavy machinery, until you know
how NovoLog® affects you.
- Do not drink alcohol or use medicines that contain
alcohol.
What are the possible side effects of NovoLog®?
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
- anxiety, irritability, mood changes, dizziness, sweating,
confusion, and headache.
Your insulin dose may need to change because of:
- weight gain or loss, increased stress, illness, or change in
diet or level of physical activity.
Other common side effects may include:
- low potassium in your blood, injection site reactions, itching,
rash, serious whole body allergic reactions, skin thickening or
pits at the injection site, weight gain, and swelling of your hands
and feet.
Get emergency medical help if you have:
- trouble breathing, shortness of breath, fast heartbeat,
swelling of your face, tongue, or throat, sweating, extreme
drowsiness, dizziness, or confusion.
Please see Prescribing Information for NovoLog at
https://www.novo-pi.com/novolog.pdf
ReliOn NovoLog® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S. © 2021
Novo Nordisk All rights reserved. June 2021
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210629005683/en/
Marilee McInnis 800-331-0085
Walmart (NYSE:WMT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Walmart (NYSE:WMT)
Historical Stock Chart
From Apr 2023 to Apr 2024